Product NDC: | 0430-3754 |
Proprietary Name: | ESTRACE |
Non Proprietary Name: | estradiol |
Active Ingredient(s): | .1 mg/g & nbsp; estradiol |
Administration Route(s): | VAGINAL |
Dosage Form(s): | CREAM |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0430-3754 |
Labeler Name: | Warner Chilcott (US), LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA086069 |
Marketing Category: | ANDA |
Start Marketing Date: | 20010701 |
Package NDC: | 0430-3754-14 |
Package Description: | 36 CARTON in 1 CASE (0430-3754-14) > 1 TUBE, WITH APPLICATOR in 1 CARTON > 42.5 g in 1 TUBE, WITH APPLICATOR |
NDC Code | 0430-3754-14 |
Proprietary Name | ESTRACE |
Package Description | 36 CARTON in 1 CASE (0430-3754-14) > 1 TUBE, WITH APPLICATOR in 1 CARTON > 42.5 g in 1 TUBE, WITH APPLICATOR |
Product NDC | 0430-3754 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | estradiol |
Dosage Form Name | CREAM |
Route Name | VAGINAL |
Start Marketing Date | 20010701 |
Marketing Category Name | ANDA |
Labeler Name | Warner Chilcott (US), LLC |
Substance Name | ESTRADIOL |
Strength Number | .1 |
Strength Unit | mg/g |
Pharmaceutical Classes | Estradiol Congeners [Chemical/Ingredient],Estrogen [EPC],Estrogen Receptor Agonists [MoA] |